Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Future Medicinal Chemistry
|
March 24, 2011
Recent drug approvals from the US FDA and EMEA: what the future holds
Paolo Pevarello
Current Medicinal Chemistry. Anti-Cancer Agents
|
September 24, 2005
An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes
Anna Vulpetti, Paolo Pevarello
Pharmaceutical Patent Analyst
|
November 19, 2013
Kinase inhibitors for CNS diseases: an analysis of the recent patent literature
Federica Amigoni, Elena Legnaghi, Paolo Pevarello
Trends in Pharmacological Sciences
|
December 7, 2007
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres, Paolo Pevarello, Mariano Barbacid, et al.
Future Medicinal Chemistry
|
March 24, 2011
Ion channel blockers for the treatment of neuropathic pain
Elena Colombo, Simona Francisconi, Laura Faravelli, et al.
Magnetic Resonance in Chemistry : MRC
|
July 1, 2010
Differentiation between [1,2,4]triazolo[1,5-a] pyrimidine and [1,2,4]triazolo[4,3-a]-pyrimidine regioisomers by 1H-15N HMBC experiments
Antonio Salgado, Carmen Varela, Ana María García Collazo, et al.
Journal of Medicinal Chemistry
|
May 31, 2002
NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands
Claudio Dalvit, Marina Fasolini, Maria Flocco, et al.
Journal of Molecular Graphics & Modelling
|
November 2, 2005
Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors
Anna Vulpetti, Elena Casale, Fulvia Roletto, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2006
A practical synthesis of the major 3-hydroxy-2-pyrrolidinone metabolite of a potent CDK2/cyclin A inhibitor
Marcella Nesi, Daniela Borghi, Maria Gabriella Brasca, et al.
Pharmaceutical Patent Analyst
|
March 5, 2014
Ca(2+) release-activated Ca(2+) channel inhibitors
Paolo Pevarello, Silvia Cainarca, Chiara Liberati, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Future Medicinal Chemistry
|
March 24, 2011
Recent drug approvals from the US FDA and EMEA: what the future holds
Paolo Pevarello
Current Medicinal Chemistry. Anti-Cancer Agents
|
September 24, 2005
An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes
Anna Vulpetti, Paolo Pevarello
Pharmaceutical Patent Analyst
|
November 19, 2013
Kinase inhibitors for CNS diseases: an analysis of the recent patent literature
Federica Amigoni, Elena Legnaghi, Paolo Pevarello
Trends in Pharmacological Sciences
|
December 7, 2007
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres, Paolo Pevarello, Mariano Barbacid, et al.
Future Medicinal Chemistry
|
March 24, 2011
Ion channel blockers for the treatment of neuropathic pain
Elena Colombo, Simona Francisconi, Laura Faravelli, et al.
Magnetic Resonance in Chemistry : MRC
|
July 1, 2010
Differentiation between [1,2,4]triazolo[1,5-a] pyrimidine and [1,2,4]triazolo[4,3-a]-pyrimidine regioisomers by 1H-15N HMBC experiments
Antonio Salgado, Carmen Varela, Ana María García Collazo, et al.
Journal of Medicinal Chemistry
|
May 31, 2002
NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands
Claudio Dalvit, Marina Fasolini, Maria Flocco, et al.
Journal of Molecular Graphics & Modelling
|
November 2, 2005
Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors
Anna Vulpetti, Elena Casale, Fulvia Roletto, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2006
A practical synthesis of the major 3-hydroxy-2-pyrrolidinone metabolite of a potent CDK2/cyclin A inhibitor
Marcella Nesi, Daniela Borghi, Maria Gabriella Brasca, et al.
Pharmaceutical Patent Analyst
|
March 5, 2014
Ca(2+) release-activated Ca(2+) channel inhibitors
Paolo Pevarello, Silvia Cainarca, Chiara Liberati, et al.
Page
of 3